Xiaojie Zhang, MD

Xiaojie Zhang, MD, a hematology/oncology fellow at UC San Diego.

Articles by Xiaojie Zhang, MD

Predicting Palbociclib Outcomes in Breast Cancer Using Deep Learning

ByJordyn Sava,Xiaojie Zhang, MD,Akshat Singhal, PhD

April 15th 2025

Xiaojie Zhang, MD, and Akshat Singhal, PhD, discuss their research leveraging deep learning to predict how patients with ER+/HER2- breast cancer will respond to palbociclib.

Xiaojie Zhang, MD

Articles by Xiaojie Zhang, MD

Predicting Palbociclib Outcomes in Breast Cancer Using Deep Learning

Latest Updated Articles

Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways

FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL

Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC

Safusidenib Shows Robust, Ongoing Responses in Grade 2 IDH1-Mutant Glioma

Sac-TMT Demonstrates Antitumor Activity, Safety in Urothelial Carcinoma

JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update